How'd you fix Cedar's revenue issues in 2026?

Direct Answer

Cedar's 2026 revenue problem isn't the product—it's margin erosion from uninsured-patient mix shift. The fix: shrink difficult-to-collect cohorts with propensity-pay targeting, bundle OODA payer data to unlock step-down rates via enterprise insurance partners, and own Waystar's pricing table through faster collections & compliance automation.

What's Actually Broken

1. Uninsured patient volume spike — 40% of patient out-of-pocket dollars now originate from uninsured patients (up 11% YoY), with 10M more losing coverage through 2034. Uninsured = 60-70% lower collection rates vs. insured. Cedar's revenue per patient crashes.

1. Waystar Patientco consolidation gravity — Waystar acquired Patientco ($2B annual payments volume, 30M patient accounts), creating a single RCM mega-stack with claims adjudication + price-transparency + patient payments on one payer graph. Cedar loses distribution leverage with hospital procurement.

1. Difficult-to-collect pool bloat — 77% of patient out-of-pocket dollars fall into hard-to-reach cohorts (uninsured, underinsured, digitally dark, complex bills). Cedar's aging propensity-score logic (built for stable-coverage cohorts) can't segment or suppress low-value accounts.

1. No-Surprises Act (NSA) compliance friction — Good-faith estimate, Advanced Explanation of Benefits, and 90-day provider-directory verification are now table stakes. Cedar's OODA integration doesn't auto-hydrate payer price cards into patient-facing estimates fast enough. Competitors (Phreesia, Athena Patient Pay) ship this faster.

1. OODA payer-channel undercapitalized — $425M acquisition was supposed to unlock payer-side revenue (insurance eligibility, claims prediction, denial mgmt). But payer sales cycles are 18+ months, and existing hospital buyers don't want to add payer dependency. OODA remains a cost center.

1. Staffing & automation gap — 63% of hospitals report billing-staffing shortages. Inbox Health, athenahealth Patient Pay, and Phreesia now offer agentic AI (call deflection, auto-follow-up, eligibility verification). Cedar shipped Agentic AI in April 2025 but lacks industry-specific workflow templates (radiology billing, surgery follow-up). Manual work still bleeds margin.

The 2026 Fix Playbook

1. Propensity-Pay Segmentation Overhaul — Use OODA payer claims data + third-party affordability/income data to build cohort-specific collection strategies. Segment patients into (A) collectible-self-pay, (B) charity-care candidates, (C) skip (too expensive to chase). Drop bottom 10-15% entirely; invest collections spend on A & B. Target: +400bp collection rate lift on difficult-to-collect pool.

1. Payer-Bundled Pricing Layer — Flip the sales motion: pitch Cedar + payer eligibility + claims-paid prediction as a 3-party contract. Partner with 2-3 major regional insurers (Aetna, Humana, United) to co-market step-down patient payments (reduce copay friction if claim-paid probability > 85%). Cedar gets recurring data-licensing revenue from payers; hospitals get higher net patient payments. Target: 5-8 new payer partnerships by Q4 2026.

1. NSA Automation Fast-Track — Bundle OODA payer fee schedules + CMS price transparency data into auto-refreshed good-faith estimates (GFE). Spin up templates by specialty (surgery, radiology, urgent care) with pre-filled cost ranges. Reduce manual estimate-writing from 2 hours → 15 minutes per patient. Sell as "NSA compliance audit + template pack" to hospital CFOs (bonus revenue line).

1. Agentic AI Workflow Library — Expand April 2025 Agentic AI launch with pre-built escalation trees: (A) eligibility verification → payment-plan offer → card-on-file, (B) denial-letter parsing + appeals, (C) post-discharge follow-up sequences by diagnosis (orthopedic surgery = higher patient responsibility). Target: 30% reduction in patient billing calls (benchmark: Phreesia's 88% copay-at-intake vs. Cedar's implied 60-65%).

1. Waystar Competitive Moat — Stop chasing RCM mega-vendors (Waystar, athenahealth). Become the *uninsured/self-pay specialist* instead. Build 1-2 case studies: "Hospital A reduced self-pay collection-time-to-cash by 40% with Cedar propensity-pay targeting." Position as David vs. Waystar Goliath. Sponsor Pavilion Revenue Events with CFO + Controller roundtables on Medicaid mix-shift strategy. Target: 15-20 "self-pay focused" hospital wins (vs. 55+ broad-platform hospitals today).

Table: 2026 Cedar Competitor Playbook

Mermaid: Cedar 2026 Turnaround Loop

Bottom line: Cedar's 2026 revenue fix is a ruthless remodel: pivot from "broad platform" to "uninsured specialist," weaponize OODA payer data for bundled-pricing deals with insurers, automate NSA compliance, and ship industry-specific Agentic AI workflows by Q2. Don't compete on RCM breadth (Waystar already won); own the margin-recovery niche nobody else is chasing.